39 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
goals and objectives relevant to the compensation of our Chief Executive Officer and other executive officers, evaluates the performance of these officers … in light of those goals and objectives and approves the compensation of these officers based on such evaluations. The compensation committee also
8-K
EX-10.1
kv1z noquebhxmlz
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
9dfb0zm722nexl1sze
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
S-1/A
EX-10.5
e6x871 hw0kslh2
23 Jan 19
IPO registration (amended)
4:39pm
S-1
EX-10.5
7yniuseypo
21 Dec 18
IPO registration
4:39pm
8-K
EX-99.2
ras6on 8a4tz7w6fd9e
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
S-1/A
ku9l5 9tf8
23 Jan 19
IPO registration (amended)
4:39pm
DEF 14A
2t2dfgxjhdf9gyabpy
30 Apr 19
Definitive proxy
4:04pm
424B4
0h70xv514
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1
lpjk6
21 Dec 18
IPO registration
4:39pm
DRS/A
23q disab
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
mhqfv3sr
11 Oct 18
Draft registration statement
12:00am
10-K
gaxt5m990c72rcz
22 Mar 19
Annual report
4:45pm